Synthego

Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.

The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platform vertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic development programs.

By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology.

The company was founded in 2012 and is based in Redwood City, California.

Synthego headquartered in United States, North America, operates in the Software, Biotechnology, Artificial Intelligence (AI), Machine Learning, Life Science, Innovation Management, Genetics, Industrial Automation sector. The company focuses on Software and has secured $132.4B in funding across 288 round(s). With a team of 251-500 employees, Synthego is actively contributing to advancements in Software. Their latest funding round, Series A - Synthego, raised $8.3M. Discover more about their projects, partnerships, and impact on our platform.